Rankings
▼
Calendar
STAA
STAAR Surgical Company
$871M
Q4 2016 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$22M
Gross Profit
$16M
71.7% margin
Operating Income
$1M
5.7% margin
Net Income
-$166,000
-0.7% margin
EPS (Diluted)
$-0.00
QoQ Revenue Growth
+10.4%
Cash Flow
Operating Cash Flow
$128,000
Free Cash Flow
-$368,000
Stock-Based Comp.
$415,000
Balance Sheet
Total Assets
$65M
Total Liabilities
$28M
Stockholders' Equity
$38M
Cash & Equivalents
$14M
Revenue Segments
Implantable Collamer Lenses
$16M
71%
Intraocular Lenses
$5M
22%
Other Surgical Products
$1M
7%
Geographic Segments
Other Countries
$14M
47%
JAPAN
$5M
17%
CHINA
$4M
14%
KOREA, REPUBLIC OF
$4M
13%
UNITED STATES
$3M
8%
← FY 2016
All Quarters
Q1 2017 →
STAA Q4 2016 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena
